SCHEMBL13554665

SCHEMBL13554665

O=C(Nc1ccc(I)c(-c2nccc3ccccc23)c1)c1ccc(N2CCC(O)CC2)nc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 4/20 0.42
▸ MCHR1 Q99705 2/20 0.41
▸ TRPV1 Q8NER1 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ RAF1 P04049 2/20 0.40
▸ BRAF P15056 1/20 0.40
▸ MAPK8 P45983 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ MALT1 Q9UDY8 1/20 0.39
▸ PDE7A Q13946 1/20 0.38
▸ KCNQ3 O43525 1/20 0.38
▸ KCNQ2 O43526 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ SOAT1 P35610 1/20 0.38
▸ ABL1 P00519 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13552792 0.90 MALT1 (0.44) DGAT1MCHR1TRPV1KCNH2RAF1
SCHEMBL13554790 0.89 RAB9A (0.50) BRAFHDAC1HDAC2NPC1RAB9A
SCHEMBL13554827 0.89 MAPT (0.49) RAF1BRAFKCNQ3KCNQ2NPC1
SCHEMBL13554803 0.89 KCNH2 (0.49) TRPV1KCNH2RAF1BRAFHDAC1
SCHEMBL13554826 0.86 TRPV1 (0.42) TRPV1KCNH2MAPK8HDAC1HDAC2
SCHEMBL12214936 0.84 HDAC1 (0.51) DGAT1MCHR1TRPV1KCNH2HDAC1
SCHEMBL13552809 0.81 TRPV1 (0.48) DGAT1MCHR1TRPV1KCNQ3KCNQ2
SCHEMBL13554599 0.81 SMN1; SMN2 (0.53) CYP3A4NPC1ALDH1A1LMNAMAPT
SCHEMBL13552803 0.79 KCNH2 (0.47) KCNH2MAPK8HDAC1HDAC2LMNA
SCHEMBL13552812 0.79 MAPT (0.54) DGAT1RAF1BRAFKCNQ3KCNQ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120270858-A1 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling CALIFORNIA CAPITAL EQUITY, LLC (US) 2012-10-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120270858-A1 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling SHH, GLI1, SMO DGAT1 2756/4885MCHR1 846/4885TRPV1 3560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback